X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22817) 22817
Book Review (6437) 6437
Publication (1098) 1098
Book Chapter (231) 231
Magazine Article (80) 80
Newsletter (70) 70
Conference Proceeding (39) 39
Book / eBook (32) 32
Newspaper Article (18) 18
Trade Publication Article (17) 17
Dissertation (9) 9
Paper (3) 3
Reference (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19329) 19329
index medicus (19244) 19244
female (10248) 10248
male (9255) 9255
middle aged (7095) 7095
venous thromboembolism (6542) 6542
adult (6221) 6221
anticoagulants - therapeutic use (5817) 5817
aged (5642) 5642
risk factors (5287) 5287
thrombosis (5119) 5119
hematology (4884) 4884
peripheral vascular disease (4600) 4600
thromboembolism (4449) 4449
venous thrombosis (4394) 4394
venous thrombosis - drug therapy (4224) 4224
treatment outcome (3858) 3858
anticoagulants (3580) 3580
deep-vein thrombosis (3188) 3188
prevention (3166) 3166
surgery (2912) 2912
abridged index medicus (2641) 2641
anticoagulants - administration & dosage (2483) 2483
molecular-weight heparin (2432) 2432
venous thrombosis - etiology (2386) 2386
medicine, general & internal (2360) 2360
retrospective studies (2315) 2315
risk (2306) 2306
pulmonary embolism (2301) 2301
aged, 80 and over (2249) 2249
anticoagulants - adverse effects (2133) 2133
care and treatment (2109) 2109
pulmonary-embolism (2108) 2108
drug therapy (2068) 2068
adolescent (1897) 1897
medicine & public health (1877) 1877
warfarin (1819) 1819
heparin (1816) 1816
venous thrombosis - prevention & control (1808) 1808
therapy (1725) 1725
heparin, low-molecular-weight - therapeutic use (1674) 1674
cancer (1673) 1673
venous thromboembolism - prevention & control (1666) 1666
time factors (1662) 1662
health aspects (1564) 1564
prospective studies (1550) 1550
risk-factors (1543) 1543
venous thromboembolism - drug therapy (1530) 1530
diagnosis (1504) 1504
venous thrombosis - diagnosis (1472) 1472
management (1470) 1470
oncology (1463) 1463
risk assessment (1432) 1432
heparin - therapeutic use (1415) 1415
fibrinolytic agents - therapeutic use (1401) 1401
complications (1381) 1381
recurrence (1374) 1374
analysis (1372) 1372
research (1361) 1361
pharmacology & pharmacy (1334) 1334
deep venous thrombosis (1326) 1326
follow-up studies (1325) 1325
prophylaxis (1316) 1316
animals (1289) 1289
incidence (1284) 1284
young adult (1275) 1275
anticoagulation (1273) 1273
pregnancy (1251) 1251
pulmonary embolism - drug therapy (1249) 1249
hemorrhage - chemically induced (1240) 1240
administration, oral (1233) 1233
venous thrombosis - complications (1188) 1188
mortality (1158) 1158
deep vein thrombosis (1130) 1130
warfarin - therapeutic use (1093) 1093
catheterization, central venous - adverse effects (1088) 1088
venous thromboembolism - etiology (1079) 1079
enoxaparin (1077) 1077
cardiac & cardiovascular systems (1072) 1072
child (1053) 1053
patients (1029) 1029
blood clot (1016) 1016
disease (1012) 1012
rivaroxaban (1001) 1001
venous thrombosis - diagnostic imaging (1000) 1000
unfractionated heparin (991) 991
stroke (923) 923
thromboprophylaxis (917) 917
prognosis (905) 905
internal medicine (900) 900
complications and side effects (898) 898
hematology, oncology and palliative medicine (874) 874
thromboembolism - prevention & control (865) 865
venous thrombosis - epidemiology (860) 860
chemotherapy (857) 857
thrombolytic therapy (856) 856
neoplasms - complications (853) 853
tomography, x-ray computed (849) 849
pulmonary embolism - prevention & control (847) 847
pulmonary embolism - etiology (846) 846
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21939) 21939
French (326) 326
German (270) 270
Spanish (149) 149
Japanese (98) 98
Russian (88) 88
Chinese (62) 62
Italian (43) 43
Polish (43) 43
Danish (31) 31
Portuguese (20) 20
Swedish (20) 20
Dutch (19) 19
Czech (18) 18
Hungarian (18) 18
Finnish (16) 16
Turkish (15) 15
Norwegian (14) 14
Korean (13) 13
Hebrew (8) 8
Romanian (7) 7
Bulgarian (4) 4
Croatian (4) 4
Serbian (3) 3
Lithuanian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e351S - e418S
Background: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This... 
SPIRAL CT VENOGRAPHY | CASE-FATALITY RATES | MAGNETIC-RESONANCE VENOGRAPHY | SERIAL IMPEDANCE PLETHYSMOGRAPHY | RESPIRATORY SYSTEM | ACUTE VENOUS THROMBOSIS | DEEP-VEIN THROMBOSIS | SUSPECTED PULMONARY-EMBOLISM | D-DIMER LEVELS | TIME COMPRESSION ULTRASONOGRAPHY | COLOR DOPPLER ULTRASOUND | CRITICAL CARE MEDICINE | Predictive Value of Tests | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Tomography, X-Ray Computed - methods | Male | Hemorrhage - prevention & control | Fibrinolytic Agents - adverse effects | Societies, Medical | Fibrinolytic Agents - therapeutic use | Adult | Female | Magnetic Resonance Angiography - methods | Venous Thrombosis - prevention & control | Thrombosis - prevention & control | Ultrasonography - methods | Venous Thrombosis - drug therapy | Fibrin Fibrinogen Degradation Products - analysis | Risk Factors | Probability | Phlebography - methods | Hemorrhage - blood | Evidence-Based Medicine | Ambulatory Care | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombosis - diagnosis | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods: We... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Circulation, ISSN 0009-7322, 07/2007, Volume 116, Issue 2, pp. 180 - 187
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 23, pp. 2240 - 2252
Journal Article